Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic+1

Recruiting

Investigational

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Investigational

Spain

Participants:0–17 years
Substances:Lebrikizumab

Contact Research Centre

Bladder transitional cell carcinoma+1

Recruiting

Registered drug

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Enfortumab Vedotin

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drugNo placebo

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Barzolvolimab

Contact Research Centre

Bronchiectasis

Recruiting

Investigational

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:GSK3862995B

Contact Research Centre

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Investigational

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Bronchiectasis

Recruiting

Investigational

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Hypereosinophilic syndrome

Recruiting

Registered drug

A Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Depemokimab

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Find therapies in clinical trials near you

295 trials match your criteria

Chronic obstructive pulmonary disease

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Dermatitis atopic+1

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Bladder transitional cell carcinoma+1

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Chronic spontaneous urticaria

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Bronchiectasis

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Chronic obstructive pulmonary disease

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Chronic obstructive pulmonary disease

Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

Bronchiectasis

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Arteriosclerosis

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Hypereosinophilic syndrome

A Study of Depemokimab and Prednisolone in Adults with Hypereosinophilic Syndrome (HES)

Neoplasm malignant

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.